Nanobiotix (NBTX) Cash & Equivalents: 2019-2024

Historic Revenue - Interest and Investment Income for Nanobiotix (NBTX) over the last 2 years, with Dec 2021 value amounting to $31.7 million.

  • Nanobiotix's Revenue - Interest and Investment Income fell 232.82% to -$78.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$173.7 million, marking a year-over-year decrease of 111.60%. This contributed to the annual value of $31.7 million for FY2021, which is 60.60% down from last year.
  • Nanobiotix's Revenue - Interest and Investment Income amounted to $31.7 million in FY2021, which was down 60.60% from $80.5 million recorded in FY2020.
  • In the past 5 years, Nanobiotix's Cash & Equivalents registered a high of $136.0 million during FY2020, and its lowest value of $53.1 million during FY2024.
  • Over the past 2 years, Nanobiotix's median Cash & Equivalents value was $67.3 million (recorded in 2023), while the average stood at $67.3 million.
  • Data for Nanobiotix's Revenue - Interest and Investment Income shows a maximum YoY crashed of 60.60% (in 2021) over the last 5 years.
  • Nanobiotix's Revenue - Interest and Investment Income (Yearly) stood at $80.5 million in 2020, then crashed by 60.60% to $31.7 million in 2021.